nach oben

Inflammopharmacology

Erschienen in:

19.08.2019 | Original Article

Hydrolysable tannin-rich fraction from Terminalia chebula Retz. fruits ameliorates collagen-induced arthritis in BALB/c mice

verfasst von: Sanmuga Priya Ekambaram, Senthamil Selvan Perumal, Thamizharasi Erusappan, Aswini Srinivasan

Erschienen in: Inflammopharmacology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Terminalia chebula Retz. (Fam: Combretaceae) (TC) is widely used in traditional system for the treatment of fever, asthma, urinary diseases, and rheumatism. The aim of the present study is to evaluate the efficacy of hydrolysable tannin-rich fraction (HTF) isolated from TC fruits in collagen-induced arthritic BALB/c mice. Type II collagen-induced arthritis was attained in BALB/c mice. HTF treatment at three gradual doses (100, 200, and 400 mg/kg) was started from 24th day on daily administration up to 4 weeks. Body weight, food intake, and increase in hind paw were monitored at weekly basis. At the end of the study, serum and joint tissues were estimated for proinflammatory cytokines and biochemical parameters and the hind limbs were removed for radiological and histopathological evaluations. Oral administration of HTF could significantly protect CIA in BALB/c mice by reducing paw volume, arthritic score, spleen index, serum and joint cytokine level, and biochemical markers. The anti-inflammatory efficacy of HTF was further demonstrated by morphological observation, histopathological , and radiological evaluations. HTF is a good therapeutic agent for the treatment of joint inflammatory condition, as its action is mediated through cytokine inhibition.

Ajala OS, Jukov A, Ma C (2014) Hepatitis C virus inhibitory hydrolysable tannins from the fruits of Terminalia chebula. Fitoterapia 99:117–123CrossRef

Bartok B, Firestein GS (2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 233(1):233–255. https://doi.org/10.1111/j.0105-2896.2009.00859.x CrossRefPubMedPubMedCentral

Brand DD, Latham KA, Rosloniec EF (2007) Collagen-induced arthritis. Nat Protoc 2(5):1269–1275. https://doi.org/10.1038/nprot.2007.173 CrossRefPubMed

Chen CX, Zhang P, Pi HF, Ruan HL, Hu ZH, Wu JZ (2010) Extacts of Arisaema rhizomatum C.E.C. Fischer attenuate inflammatory response on collagen-induced arthritis in BALB/c mice. J Ethnopharmacol 133:573–582. https://doi.org/10.1016/j.jep.2010.10.035 CrossRef

Cock IE (2015) The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae). Inflammopharmacology 23(5):203–229. https://doi.org/10.1007/s10787-015-0246-z CrossRefPubMed

Curtis JR, Xie F, Yun H, Bernatsky S, Winthrop KL (2016) Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis. Ann Rheum Dis 75(10):1843–1847. https://doi.org/10.1136/annrheumdis-2016-209131 CrossRefPubMedPubMedCentral

Das ND, Jung KH, Park JH, Mondol MA, Shin HJ, Lee HS, Park KS, Choi MR, Kim KS, Kim MS, Lee SR, Chai YG (2011) Terminalia chebula extract acts as a potential NF-κB inhibitor in human lymphoblastic T cells. Phytother Res 25(6):927–934. https://doi.org/10.1002/ptr.3398 CrossRefPubMed

Han Q, Song J, Qiao C, Wong L, Xu H (2006) Preparative isolation of hydrolysable tannins chebulagic acid and chebulinic acid from Terminalia chebula by high-speed counter-current chromatography. J Sep Sci 29(11):1653–1657CrossRef

Henderson B, Pettipher ER (1989) Arthritogenic actions of recombinant IL-1 and TNF in the rabbit: Evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol 75(2):306–310PubMedPubMedCentral

Jalal H, O’Dell JR, Bridges SL Jr, Cofield S, Curtis JR, Mikuls TR, Moreland LW, Michaud K (2016) Cost-effectiveness of triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis. Arthritis Care Res (Hoboken) 68(12):1751–1757. https://doi.org/10.1002/acr.22895 CrossRef

Jia N, Chu W, Li Y, Ding L, Duan J, Cui J, Cao S, Zhao C, Wu Y, Wen A (2016) Iridoid glycosides from the flowers of Gentiana macrophylla Pall ameliorate collagen-induced arthritis in rats. J Ethnopharmacol 189:1–9CrossRef

Jorgensen KK, Olsen IC, Goll GL, Lorentzen M, Bolstad N, Haavardsholm EA, Lundin KEA, Mørk C, Jahnsen J, Kvien TK (2017) Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial. Lancet 389(10086):2304–2316. https://doi.org/10.1016/S0140-6736(17)30068-5 CrossRefPubMed

Juang LJ, Sheu SJ, Lin TC (2004) Determination of hydrolyzable tannins in the fruit of Terminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresis. J Sep Sci 27(9):718–724. https://doi.org/10.1002/issc.200401741 CrossRefPubMed

Kumar R, Arora R, Agarwal A, Gupta YK (2018) Protective effect of Terminalia chebula against seizures, seizure-induced cognitive impairment and oxidative stress in experimental models of seizures in rats. J Ethnopharmacol 215:124–131CrossRef

Lee S, Hyun P, Kim S, Kim K, Lee S, Kim B, Maeng P, Lim J (2005) Suppression of the onset and progression of collagen-induced arthritis by chebulagic acid screened from a natural product library. Arthritis Rheum 52(1):345–353. https://doi.org/10.1002/art.20715 CrossRefPubMed

Lee DY, Kim HW, Yang H, Sung SH (2017) Hydrolysable tannins from the fruits of Terminalia chebula Retz and their α-glucosidase inhibitory activities. Phytochemistry 137:109–116CrossRef

McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205–2219. https://doi.org/10.1056/NEJMra1004965 CrossRefPubMed

Misra DP, Agarwal V, Negi VS (2016) Rheumatology in India: a Bird's eye view on organization, epidemiology, training programs and publications. J Korean Med Sci 31(7):1013–1019. https://doi.org/10.3346/jkms.2016.31.7.1013 CrossRefPubMedPubMedCentral

Nadkarni KM (2011) Indian materia medica. Popular Prakashan Private Limited, Mumbai, pp 1205–1210

Nair V, Singh S, Gupta YK (2010) Anti-arthritic and disease modifying activity of Terminalia chebula Retz. in experimental models. J Pharm Pharmacol 62(12):1801–1806. https://doi.org/10.1111/j.2042-7158.2010.01193.x CrossRefPubMed

Nair V, Kumar R, Singh S, Gupta YK (2012) Anti-granuloma activity of Terminalia chebula Retz. in wistar rats. Eur J Inflamm 10(2):185–192. https://doi.org/10.1177/1721727X1201000203 CrossRef

Niino-Nanke Y, Akama H, Hara M, Kashiwazaki S (1998) Alkaline phosphatase (ALP) activity in rheumatoid arthritis (RA): its clinical significance and synthesis of ALP in RA synovium. Ryumachi 38(4):581–588PubMed

Nishida K, Komiyama T, Miyazawa S, Shen ZN, Furumatsu T, Doi H, Yoshida A, Yamana J, Yamamura M, Ninomiya Y, Inoue H, Asahara H (2004) Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21 (WAF1/Cip1) expression. Arthritis Rheum 10:3365–3376CrossRef

Pellati F, Bruni R, Righi D, Grandini A, Tognolini M, Prencipe FP, Poli F, Benvenuti S, Rio DD, Rossi D (2013) Metabolite profiling of polyphenols in a Terminalia chebula Retzius ayurvedic decoction and evaluation of its chemopreventive activity. J Ethnopharmacol 147(2):277–285CrossRef

Reddy DB, Reddanna P (2009) Chebulagic acid (CA) attenuates LPS-induced inflammation by suppressing NF-kappaB and MAPK activation in RAW 264.7 macrophages. Biochem Biophys Res Commun 381(1):112–117. https://doi.org/10.1016/j.bbrc.2009.02.022 CrossRefPubMed

Rioja I, Bush KA, Buckton JB, Dickson MC, Life PF (2004) Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. Clin Exp Immunol 137(1):65–73CrossRef

Sanmuga Priya E, Keerthi B, Senthamil Selvan P, Durga R (2018) Repeated oral dose toxicity study on hydrolysable tannin rich fraction isolated from fruit pericarps of Terminalia chebula Retz. in Wistar albino rats. Regul Toxicol Pharmacol 92:182–188. https://doi.org/10.1016/j.yrtph.2017.12.001 CrossRef

Seo JB, Jeong JY, Park JY, Jun EM, Lee SI, Choe SS, Park DY, Choi EW, Seen DS, Lim JS, Lee TG (2012) Anti-arthritic and analgesic effect of NDI10218, a standardized extract of Terminalia chebula, on arthritis and pain model. Biomol Ther (Seoul) 20(1):104–112. https://doi.org/10.4062/biomolther.2012.20.1.104 CrossRef

Shashtri S, Nidan M (1985) Part I, 15th edn, Ch 25. Chaukhambha Sanskrit Sansthan, Varanasi, p 460

Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH, Strand V, Yamamoto K (2018) Rheumatoid arthritis. Nat Rev Dis Prim 8(4):18001. https://doi.org/10.1038/nrdp.2018.1 CrossRef

Srirangan S, Choy EH (2010) The role of interleukin 6 in the pathophysiology of rheumatoid arthritis. Ther Adv Musculoskelet Dis 2(5):247–256. https://doi.org/10.1177/1759720X10378372 CrossRefPubMedPubMedCentral

Sunita SK, Babita Y, Pradeep D, Deep VC, Bikratan D, Sangeeta S, Shashi G, Jain AK, Swami GK, Maheswar T, Saiprasad Alok S, Sahu DS, Tapasi B, Rao MM, Renu M, Kumawat VB, Pitta S, Singh KK, Mehar SK, Dinesh B, Kumari Rajesh, Rakesh R, Richa S, Narayanam S (2017) Clinical safety of selected ayurvedic formulations in rheumatoid arthritis. J Res Ayur Sci 1(2):108–116

Thompson AE, Rieder SW, Pope JE (2011) Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials. Arthr Rheum 63(6):1479–1485. https://doi.org/10.1002/art.30310 CrossRef

Vande Loo AAJ, Vanden Berg WB (1990) Effects of murine recombinant IL-1 on synovial joints in mice: measurements of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis 49(4):238–245CrossRef

Wang Y, Sun W, Chen L, Xu X, Wu Y, Zhang J, Zhang Y (2015) Anti-arthritic activity of Fu-Fang-Lu-Jiao-Shuang on collagen-induced arthritis in Balb/c mice and its underlying mechanisms. Pharmacogn Mag 11(42):242–249. https://doi.org/10.4103/0973-1296.153065 CrossRefPubMedPubMedCentral

WHO (2018) Chronic Diseases and Health promotion. https://www.who.int/chp/topics/rheumatic/en/. Assessed 2 Sept 2018

World Health Organization (WHO) (1998) Quality control methods for medicinal plant materials. World Health Organization, Geneva

Zhao Y, Liu F, Liu Y, Zhou D, Dai Q, Liu S (2015) Anti-arthritic effect of chebulanin on collagen induced arthritis in mice. PLoS ONE 10(9):e0139052. https://doi.org/10.1371/journal.pone.0139052 CrossRefPubMedPubMedCentral

Titel: Hydrolysable tannin-rich fraction from Terminalia chebula Retz. fruits ameliorates collagen-induced arthritis in BALB/c mice
verfasst von: Sanmuga Priya Ekambaram
Senthamil Selvan Perumal
Thamizharasi Erusappan
Aswini Srinivasan
Publikationsdatum: 19.08.2019
Verlag: Springer International Publishing
Erschienen in: Inflammopharmacology / Ausgabe 1/2020
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-019-00629-x

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Polygalasaponin F treats mice with pneumonia induced by influenza virus

Anti-inflammatory effect of bee venom in phthalic anhydride-induced atopic dermatitis animal model

Therapeutic potential of IKK-β inhibitors from natural phenolics for inflammation in cardiovascular diseases

Pharmacological potential of alkylamides from Acmella oleracea flowers and synthetic isobutylalkyl amide to treat inflammatory pain

Therapeutic potential of quercetin on human breast cancer in different dimensions

Imatinib modulates pro-inflammatory microenvironment with angiostatic effects in experimental lung carcinogenesis